GlassScriptPhysician profile
Kapisthalam S Kumar
NPI 1255335758
$22,414.96
in general payments reported to CMS, 2019-2025
84 companies · $4,448 in 2025
The $4,448 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,448 · 2020: $2,367 · 2021: $2,122 · 2022: $3,418 · 2023: $3,856 · 2024: $3,755 · 2025: $4,448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,850.51 |
| Education | $209.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,694.36 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,430.30 | 2019-2025 | Opdivo, Opdualag, Krazati |
| Merck Sharp & Dohme LLC | $1,421.22 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Astrazeneca Pharmaceuticals LP | $1,260.12 | 2019-2025 | Enhertu, Imfinzi, Datroway |
| Pfizer INC. | $1,070.66 | 2019-2025 | |
| Celgene Corporation | $896.20 | 2019-2025 | Reblozyl, Opdualag, Pomalyst |
| Incyte Corporation | $837.56 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Lilly USA, LLC | $833.74 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Janssen Biotech, INC. | $822.22 | 2019-2025 | Darzalex, Rybrevant, Tecvayli |
| Bayer Healthcare Pharmaceuticals INC. | $786.39 | 2019-2025 | |
| Seagen INC. | $749.46 | 2019-2023 | Adcetris, Tukysa, Padcev |
| Gilead Sciences, INC. | $743.56 | 2019-2025 | Trodelvy |
| Daiichi Sankyo INC. | $705.69 | 2020-2025 | Enhertu, Datroway |
| Astellas Pharma US INC | $636.21 | 2019-2025 | Xtandi, Vyloy, Padcev |
| Genzyme Corporation | $569.22 | 2019-2025 |
Show all 84 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $566.43 | 2019-2024 | Itovebi, Phesgo, Polivy |
| Glaxosmithkline, LLC. | $530.09 | 2019-2025 | Ojjaara, Jemperli, Zejula |
| Abbvie INC. | $487.93 | 2019-2025 | |
| Kite Pharma, INC. | $478.55 | 2020-2025 | Yescarta |
| Amgen INC. | $414.84 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $375.63 | 2021-2025 | Libtayo |
| Array Biopharma INC | $333.71 | 2020-2025 | Braftovi, Mektovi, Lorbrena |
| Eisai INC. | $324.34 | 2019-2025 | |
| Aveo Pharmaceuticals, INC. | $271.59 | 2022-2025 | Fotivda |
| Mirati Therapeutics, INC. | $254.15 | 2023-2024 | Krazati |
| Jazz Pharmaceuticals INC. | $249.74 | 2021-2025 | |
| Puma Biotechnology, INC. | $192.91 | 2019-2024 | |
| Alexion Pharmaceuticals, INC. | $177.00 | 2019-2025 | Ultomiris |
| Emd Serono, INC. | $164.28 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $159.80 | 2020-2025 | Fruzaqla, Alunbrig, Iclusig |
| Pharmacyclics LLC, An Abbvie Company | $150.37 | 2019-2023 | Imbruvica |
| Agios Pharmaceuticals, INC. | $143.50 | 2019-2025 | Pyrukynd |
| Immunomedics, INC. | $132.72 | 2020 | |
| Exelixis INC. | $127.26 | 2019-2024 | Cabometyx |
| Servier Pharmaceuticals LLC | $126.28 | 2021-2024 | |
| Beigene USA, INC. | $116.46 | 2021-2024 | Brukinsa |
| Pharmacosmos Therapeutics INC. | $107.74 | 2023-2025 | Monoferric, Cosela |
| Tempus Ai, INC | $102.14 | 2024 | Xt Cdx |
| Sobi, INC | $92.91 | 2023-2025 | |
| Ipsen Biopharmaceuticals, INC | $89.43 | 2022-2025 | Onivyde, Somatuline Depot |
| Pharmaessentia USA Corporation | $89.39 | 2023-2025 | Besremi |
| Legend Biotech USA INC. | $87.49 | 2025 | Carvykti |
| Geron Corporation | $86.08 | 2025 | Rytelo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.24 | 2019-2022 | |
| Blueprint Medicines Corporation | $81.07 | 2023-2025 | Ayvakit |
| Janssen Pharmaceuticals, INC | $65.80 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $63.15 | 2023-2024 | Orgovyx |
| Beone Medicines USA, INC. | $61.03 | 2025 | Brukinsa |
| Myovant Sciences INC. | $60.92 | 2021-2022 | |
| G1 Therapeutics, INC. | $58.24 | 2022-2023 | Cosela |
| Rigel Pharmaceuticals, INC. | $57.55 | 2019-2023 | Rezlidhia, Tavalisse |
| Tesaro, INC. | $53.16 | 2019 | |
| Global Blood Therapeutics, INC. | $52.88 | 2020-2022 | |
| Stemline Therapeutics INC. | $52.77 | 2023-2025 | Orserdu |
| Morphosys, US INC. | $52.57 | 2022-2023 | Monjuvi |
| Karyopharm Therapeutics INC. | $52.25 | 2020-2024 | Xpovio |
| Medtronic, INC. | $50.59 | 2022 | |
| Octapharma USA, INC. | $50.20 | 2020 | |
| Sun Pharmaceutical Industries INC. | $46.10 | 2025 | |
| Novocure INC. | $46.04 | 2024-2025 | Optune Lua (Novottf-200t) |
| Advanced Accelerator Applications | $41.86 | 2019-2020 | |
| Ge Healthcare | $40.09 | 2022 | |
| Amag Pharmaceuticals, INC. | $39.78 | 2020-2022 | |
| Foundation Medicine, INC. | $32.43 | 2023 | |
| Taiho Oncology, INC. | $30.94 | 2019-2023 | |
| Acrotech Biopharma INC. | $29.87 | 2025 | Beleodaq |
| Nuvation Bio INC. | $28.28 | 2025 | Ibtrozi |
| Tersera Therapeutics LLC | $25.72 | 2019 | |
| Iovance Biotherapeutics, INC. | $23.90 | 2025 | Amtagvi |
| Immunogen, INC. | $22.47 | 2023 | Elahere |
| Azurity Pharmaceuticals, INC. | $22.12 | 2025 | Danziten |
| Genmab U.S., INC. | $19.55 | 2023 | Epkinly |
| Eusa Pharma (US) LLC | $18.63 | 2022 | |
| Epizyme, INC. | $17.65 | 2021 | |
| Apellis Pharmaceuticals, INC. | $16.86 | 2023 | Empaveli |
| Syndax Pharmaceuticals, INC. | $16.64 | 2025 | |
| Recordati_rare_diseases_inc. | $16.12 | 2025 | Enjaymo |
| Cti Biopharma Corp. | $16.12 | 2023 | Vonjo |
| Innate Pharma, INC | $14.94 | 2020 | |
| Deciphera Pharmaceuticals INC. | $14.53 | 2021 | |
| Secura Bio, INC. | $14.47 | 2023 | Copiktra |
| Adc Therapeutics America, INC. | $12.90 | 2021 | |
| Myriad Genetic Laboratories, INC. | $11.44 | 2022 | |
| Clovis Oncology, INC. | $10.42 | 2019 |
Drugs and devices associated with these payments
Keytruda $798Enhertu $658Reblozyl $498Opdivo $487Jakafi $360Nubeqa $330Verzenio $329Tukysa $327Libtayo $319Jaypirca $319Trodelvy $317Krazati $297Ibrance $279Padcev $273Xofigo $268Darzalex $263Monjuvi $254Adcetris $247Yescarta $233Kisqali $228Lynparza $226Opdualag $218Xtandi $206Braftovi $197Imbruvica $178Zynyz $172Mektovi $172Pluvicto $172Venclexta $169Sarclisa $167Datroway $147Inlyta $142Zepzelca $139Rybrevant $132Lorbrena $132Imfinzi $129Epkinly $129Vitrakvi $125Stivarga $125Comirnaty $124Brukinsa $123Tecvayli $117Orgovyx $115Calquence $114Ultomiris $112Ojjaara $110Elahere $110Tabrecta $105Erleada $104Fotivda $103Ayvakit $98.54Piqray $96.31Fabhalta $95.97Vonjo $93.52Besremi $89.39Carvykti $87.49Rytelo $86.08Scemblix $82.31Cosela $81.82Xt Cdx $81.74Promacta $81.70Bosulif $78.45Vyloy $76.46Tibsovo $75.00Somatuline Depot $73.13Onivyde $73.13Retevmo $72.22Pyrukynd $68.93Monoferric $68.90Mekinist $61.29Fruzaqla $59.70Elrexfio $57.23Orserdu $52.77Idhifa $52.47Jevtana $46.30Odomzo $46.10Optune Lua (Novottf-200t) $46.04Xalkori $45.93Lenvima $45.33Cabometyx $43.29Tivdak $43.16Talzenna $40.48Welireg $39.13Besponsa $37.50Jemperli $36.58Zejula $36.58Enjaymo $35.28Xospata $34.25Paxlovid $33.78Oxbryta $33.37Alunbrig $31.69Shingrix $31.58Itovebi $29.96Polivy $29.96Phesgo $29.96Beleodaq $29.87Lutathera $29.35Tecentriq $28.98Ibtrozi $28.28Oncaspar $27.48
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kapisthalam Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.